Bruker Corporation (BRKR)

Michael Burry, the legendary “Big Short” investor and founder of Scion Asset Management has revealed a substantial reshuffle in his Q2 2025 holdings, adding heavyweight names across healthcare, retail...

Bruker faces significant headwinds due to NIH funding cuts, heavy reliance on academia, and declining financial performance versus peers. Despite operational challenges and a sharp drop in valuation, ...

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.0...

BRKR's Q2 profit drops sharply, revenues decrease, and weak demand leads to guidance cuts despite cost-saving plans.

Explore Bruker's (BRKR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

ETTLINGEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the signing of multiple new contracts and framework agreements for its explosives and chemical tr...

Bruker Corporation BRKR reported worse-than-expected second-quarter financial results and cut its FY25 guidance on Monday.

Bruker Corporation BRKR is currently in the 17th phase of its 18-phase Adhishthana cycle on the weekly chart and signals point to potential trouble ahead. While several large financial institutions re...

Bruker Corporation (NASDAQ:BRKR ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Frank H. Laukien - Chairman, CEO & President Gerald N.

The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates ...